Last reviewed · How we verify
NCT02477579
A Prospective, Multi-Center, Pivotal Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter in Facilitating Crossing Chronic Total Occlusion (CTO) Coronary Lesions
NA trial testing NovaCross in Chronic Total Occlusion of Coronary Artery in 145 participants. Completed in 10 August 2017.
10 August 2017
Quick facts
| Lead sponsor | Nitiloop Ltd. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 145 |
| Start date | 17 May 2015 |
| Primary completion | 10 August 2017 |
| Estimated completion | 10 August 2017 |
| Sites | 5 locations across United States, Poland |
Drugs / interventions tested
- NovaCross
Conditions studied
- Chronic Total Occlusion of Coronary Artery — all drugs for Chronic Total Occlusion of Coronary Artery →
Sponsor
Nitiloop Ltd.
Who can join
Adults 18 to 80, any sex, with Chronic Total Occlusion of Coronary Artery. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the safety and effectiveness of the a novel device called NovaCross to help cross Chronic Total Occlusion (CTO) lesions in coronary arteries.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02477579
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NovaCross
Trials testing the same drug.
- NCT04862559 — A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions · NA · completed
Other recruiting trials for Chronic Total Occlusion of Coronary Artery
Currently open trials in the same condition.
- NCT06414551 — Calcification on CTCA of a CTO and PCI Outcomes · recruiting
- NCT06193954 — VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions · NA · recruiting
- NCT03756870 — Revascularization Versus Optimal Medical Therapy of Chronic Total Coronary Occlusions on Left Ventricular Ischemia Reduc · NA · recruiting
- NCT03563417 — ISCHEMIA-CTO Trial - Revascularisation or Optimal Medical Therapy of CTO · NA · recruiting
- NCT03392415 — The NOrdic-Baltic Randomized Registry Study for Evaluation of PCI in Chronic Total Coronary Occlusion · NA · active not recruiting
Other Nitiloop Ltd. trials
Trials by the same sponsor.
- NCT03717675 — Supplemental Study to Evaluate the Safety and Effectiveness of the NovaCross™ Micro-catheter · NA · completed
- NCT04862559 — A Single Center Study to Evaluate the Safety of the NovaCross Microcatheter in Crossing Chronic Total Occlusions · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02477579 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nitiloop Ltd.
- Last refreshed: 17 August 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02477579.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing